PharmSwed – Pharmaceuticals Sales & Development Sweden AB is a Swedish pharmaceutical company developing and producing pharmaceuticals in Sweden.
Initially PharmSwed has chosen to focus on developing pharmaceuticals within the area of neurology. The first product developed by PharmSwed is Apomorfin PharmSwed. It is a further development of Apomorfin APL by PharmSwed in cooperation with APL (Apotek Produktion och Laboratorier AB).
In 2010 Apomorfin PharmSwed was approved in Sweden as first country and is produced by APL in Umeå, Sweden.
Today Apomorfin PharmSwed is approved in 7 additional European countries; Germany, UK, Ireland, The Netherlands, Denmark, Norway and Iceland.
For more information please contact us.
Pharmaceuticals Sales & Development Sweden AB
SE-115 41 Stockholm
Phone: +46 (0) 8 601 22 22